Literature DB >> 19330469

Identification of human gastric carcinoma biomarkers by differential protein expression analysis using 18O labeling and nanoLC-MS/MS coupled with laser capture microdissection.

ZhiQiang Zhang1, MaoYu Li, GuiYing Zhang, Pen Fang, HuiXing Yao, ZhiQiang Xiao, ZhuChu Chen.   

Abstract

Early detection and rational therapy for gastric cancer are crucial. In this study we undertook comparative proteomics for identification of gastric carcinoma biomarkers using pooled laser capture microdissected GA cells and matched nonmalignant gastric mucosa epithelial cells. The method involved separation of total proteins by 1D SDS-PAGE, trypsin digestion, and postdigest (18)O/(16)O labeling followed by nano-HPLC-MS/MS for peptide identification and relative quantification. A total of 78 differentially expressed proteins were identified, among these proteins, 42 proteins were up-regulated in GA and 36 proteins were down-regulated. Some differentially expressed proteins were further validated by western blot analysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330469     DOI: 10.1007/s12032-009-9208-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  19 in total

1.  Femtomol sensitivity post-digest (18)O labeling for relative quantification of differential protein complex composition.

Authors:  Marcus Bantscheff; Birgit Dümpelfeld; Bernhard Kuster
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

2.  A strategy for distinguishing modified peptides based on post-digestion 18O labeling and mass spectrometry.

Authors:  Gang Sun; Vernon E Anderson
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

3.  18O-labeling quantitative proteomics using an ion trap mass spectrometer.

Authors:  Jun Sakai; Shinichi Kojima; Kazunori Yanagi; Masaharu Kanaoka
Journal:  Proteomics       Date:  2005-01       Impact factor: 3.984

4.  Laser capture microdissection.

Authors:  M R Emmert-Buck; R F Bonner; P D Smith; R F Chuaqui; Z Zhuang; S R Goldstein; R A Weiss; L A Liotta
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

5.  Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.

Authors:  Zheng Fu; Yasuhide Kitagawa; Ronglai Shen; Rajal Shah; Rohit Mehra; Daniel Rhodes; Peter J Keller; Atsushi Mizokami; Rodney Dunn; Arul M Chinnaiyan; Zhi Yao; Evan T Keller
Journal:  Prostate       Date:  2006-02-15       Impact factor: 4.104

Review 6.  Proteolytic 18O-labeling strategies for quantitative proteomics.

Authors:  Masaru Miyagi; K C Sekhar Rao
Journal:  Mass Spectrom Rev       Date:  2007 Jan-Feb       Impact factor: 10.946

Review 7.  The epidemiology of gastric cancer.

Authors:  David M Roder
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

Review 8.  Gastric cancer: epidemiology, pathology and treatment.

Authors:  S R Alberts; A Cervantes; C J H van de Velde
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

Review 9.  Proteomics in cancer.

Authors:  M A Reymond; W Schlegel
Journal:  Adv Clin Chem       Date:  2007       Impact factor: 5.394

10.  Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 18O stable isotope labeling.

Authors:  Catherine S Lane; Yuqin Wang; Richard Betts; William J Griffiths; Laurence H Patterson
Journal:  Mol Cell Proteomics       Date:  2007-02-11       Impact factor: 5.911

View more
  6 in total

1.  RKIP and 14-3-3ε exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently.

Authors:  Lu Yan; Huan Gu; Jia Li; Meihua Xu; Ting Liu; Yueming Shen; Bolin Chen; Guiying Zhang
Journal:  Dig Dis Sci       Date:  2012-08-17       Impact factor: 3.199

Review 2.  Potential prognostic, diagnostic and therapeutic markers for human gastric cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Cheng Chi; Yi-Hsin Tseng; Kwang-Huei Lin
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

3.  Filamin C, a dysregulated protein in cancer revealed by label-free quantitative proteomic analyses of human gastric cancer cells.

Authors:  Jie Qiao; Shu-Jian Cui; Lei-Lei Xu; Si-Jie Chen; Jun Yao; Ying-Hua Jiang; Gang Peng; Cai-Yun Fang; Peng-Yuan Yang; Feng Liu
Journal:  Oncotarget       Date:  2015-01-20

4.  Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line.

Authors:  Huan Gu; Xianquan Zhan; Guiying Zhang; Lu Yan; William Cs Cho; Maoyu Li; Ting Liu; Zhuchu Chen
Journal:  BMC Cancer       Date:  2013-11-09       Impact factor: 4.430

Review 5.  Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Wei Huang; Hsiang-Cheng Chi; Yang-Hsiang Lin; Pei-Hsuan Lu; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2016-06-16       Impact factor: 5.923

6.  Profiling the tumor microenvironment proteome in prostate cancer using laser capture microdissection coupled to LC⿿MS⿿A technical report.

Authors:  L Staunton; C Tonry; R Lis; S Finn; J O Leary; M Loda; M Bowden; S R Pennington
Journal:  EuPA Open Proteom       Date:  2015-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.